StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$34.07−0.32 (-0.93%)

Close on Nov 18, 2026Market cap $2.25BP/E 6.3Yield –

Lakefront Biotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lakefront Biotherapeutics's market cap was $2.20B on Nov 11, 2026, against $2.06B a year earlier. Over the last 5 years it ranged from $1.52B to $4.39B, with a median of $2.20B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.20B+2.0%
2025Dec 31, 2025$2.15B+18.9%
2024Dec 31, 2024$1.81B-32.2%
2023Dec 29, 2023$2.67B-8.1%
2022Dec 30, 2022$2.91B-19.0%
2021Dec 31, 2021$3.59B-37.1%
2020Dec 31, 2020$5.70B-47.1%
2019Dec 31, 2019$10.78B+137.5%
2018Dec 31, 2018$4.54B+2.3%
2017Dec 29, 2017$4.44B+93.6%
2016Dec 30, 2016$2.29B–

More Lakefront Biotherapeutics figures

See a number that looks wrong?